Vimarsana
Biggest News Aggregation in the World

Antibody Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antibody Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antibody Platform Today - Breaking & Trending Today

SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979 - Vimarsana News

SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979

/PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharmaceutical company in immunocytokines with full-set of...

AI Proteins Secures $18.2 Million Seed Round to Pioneer High-Throughput Platform for Advanced Minipr - Vimarsana News

AI Proteins Secures $18.2 Million Seed Round to Pioneer High-Throughput Platform for Advanced Minipr

Company to focus on the rapid development of miniproteins tailor-made for therapeutics, driving down costs and shortening the time required to develop safer, more effective medicines.BOSTON--(BUSINESS WIRE)--#denovo--AI Proteins, the biotechnology company using artificial intelligence to design synthetic proteins de...

SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972 - Vimarsana News

SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972

/PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharma in immunocytokines with full-set of capabilities from discovery...